Funct. Mater. 2017; 24 (4): 660-666.
Poly(lactic acid) scaffolds modified by gelatin for the controlled release of tetrandrine in vitro
1 Department of Pharmaceutical Sciences, Zibo Vocational Institute, Zibo, Shandong 255314, China
2 Research Center of Traditional Chinese Medicine, Tianjin University of Traditional Chinese Medicine, Tianjin 300193, China
To mimic natural extracellular matrix architecture, tetrandrine-loaded poly(L-lactic acid) scaffolds modified by gelatin were prepared via phase separation, solvent replacement and freeze-drying. The purpose of this work was to combine the biological effects of tetrandrine and the advantages of poly(L-lactic acid) scaffolds which was modified by gelatin to enhancing the mass transfer features of controlled release systems. Tetrandrine contained in the scaffolds was confirmed by X-ray photoelectron spectroscopy (XPS) and Fourier-transform infrared (FT-IR) spectroscopy. Tetrandrine did not change the morphous, crystallinity and thermodynamics of the scaffolds which demonstrated by differential scanning calorimetry (DSC), scanning electron microscopy (SEM) and X-ray powder diffractometry (XRD). The results of this study showed a sustained release with 79.15% for 188 days in vitro.
1. B. Aslan, S. Guler, A. Tevlek and H. M. Aydin, J Biomed Mater Res B Appl Biomater, 2017. [Epub ahead of print] doi: 10.1002/jbm.b.34022. https://doi.org/10.1002/jbm.b.34022
2. G. Conoscenti, T. Schneider, K. Stoelzel, F. Carfi Pavia, V. Brucato, C. Goegele, V. La Carrubba and G. Schulze-Tanzil, Mater Sci Eng C Mater Biol Appl, 80, 449, 2017. https://doi.org/10.1016/j.msec.2017.06.011
3. Y.-L. Cui, X.-M. Gao, J.-S. Tian and K.-D. Yao, In: 2nd International Conference on Bioinformatics and Biomedical Engineering, iCBBE, pp.1480-1483. 2008.
4. Y. L. Cui, X. Hou, A. D. Qi, X. H. Wang, H. Wang, K. Y. Cai, Y. Ji Yin and K. De Yao, J Biomed Mater Res A, 66, 770, 2003. https://doi.org/10.1002/jbm.a.10071
5. Y. L. Cui, Y. B. Zhang, X. M. Gao and K. D. Yao, Cell Research, 16, S48, 2006.
6. N. Eslahi, M. R. Hadjighassem, M. T. Joghataei, T. Mirzapour, M. Bakhtiyari, M. Shakeri, V. Pirhajati, P. Shirinbayan and M. Koruji, Int J Nanomedicine, 8, 4563, 2013.
7. S. Gao, Y. L. Cui, C. Q. Yu, Q. S. Wang and Y. Zhang, Behav Brain Res, 238, 79, 2013. https://doi.org/10.1016/j.bbr.2012.10.015
8. Y. H. Gong, Q. L. Zhou, C. Y. Gao and J. C. Shen, Acta Biomaterialia, 3, 531, 2007. https://doi.org/10.1016/j.actbio.2006.12.008
9. Y. C. Hsu, Y. T. Chiu, C. C. Cheng, C. F. Wu, Y. L. Lin and Y. T. Huang, J. Gastroenterology Hepatology, 22, 99, 2007. https://doi.org/10.1111/j.1440-1746.2006.04361.x
10. Y. C. Hsu, Y. T. Chiu, C. Y. Lee, C. F. Wu and Y. T. Huang, Canadian J. Physiology . Pharmacology,84, 967,2006. https://doi.org/10.1139/y06-050
11. H. S. Kim, Y. H. Zhang and Y. P. Yun, Planta Medica, 65, 135, 1999. https://doi.org/10.1055/s-1999-13974
12. H. W. Kim, J. C. Knowles and H. E. Kim, J Mater Sci Mater Med,16, 189, 2005. https://doi.org/10.1007/s10856-005-6679-y
13. J. T. Liou, Z. Y. Chen, L. J. Ho, S. P. Yang, D. M. Chang, C. C. Liang and J. H. Lai, Eur.J. Pharmacology, 589, 288, 2008. https://doi.org/10.1016/j.ejphar.2008.04.056
14. P. X. Ma and R. Zhang, J Biomed Mater Res, 46, 60, 1999. https://doi.org/10.1002/(SICI)1097-4636(199907)46:1<60::AID-JBM7>3.0.CO;2-H
15. J. Nakamatsu, F. G. Torres, O. P. Troncoso, Y. Min-Lin, A. R. Boccaccini, Biomacromol., 7, 3345, 2006. https://doi.org/10.1021/bm0605311
16. N. Sekiya, H. Hikiami, K. Yokoyama, K. Kouta, L. Sakakibara, Y. Shimada and K. Terasawa, Biological & Pharmaceutical Bulletin, 28,667, 2005. https://doi.org/10.1248/bpb.28.667
17. W. K. Seow, A. Ferrante, S. Y. Li and Y. H. Thong, Int Arch Allergy Appl Immunol, 85, 404,1988. https://doi.org/10.1159/000234542
18. H. J. Tao, J. Zhang, X. L. Wang and J. L. Gao, J. Polymer Scie.Part B-Polymer Phys., 45, 153, 2007. https://doi.org/10.1002/polb.20885
19. F. Tsuji, Polymer, 43, 1789, 2002. https://doi.org/10.1016/S0032-3861(01)00752-2
20. H. L. Wang, X. H. Zhang and T. H. Chang, Acta Pharmacologica Sinica, 23, 1114, 2002.
21. Q. S. Wang, Y. L. Cui, L. N. Gao, Y. Guo, R. X. Li and X. Z. Zhang, J Biomed Mater Res A, 102, 4098, 2014. https://doi.org/10.1002/jbm.a.35083
22. L. N. Woodard, K. T. Kmetz, A. A. Roth, V. M. Page and M. A. Grunlan, Biomacromolecules, 2017. [Epub ahead of print]
23. S. J. Wu and L. T. Ng, Biological & Pharmaceutical Bulletin, 30, 59, 2007. https://doi.org/10.1248/bpb.30.59
24. S. N. Wu, H. F. Li and Y. C. Lo, J.Pharm. Experim. Therapeutics, 292, 188, 2000.
25. F. Yang, R. Murugan, S. Ramakrishna, X. Wang, Y. X. Ma and S. Wang, Biomaterial, 25, 1891, 2004. https://doi.org/10.1016/j.biomaterials.2003.08.062
26. C. Yuan lu, Q. Ai di, L. Ke Feng and Y. Kang de, Tianjin, J. Traditional Chinese Medicine, 22,236, 2005.
27. X. Y. Yuan, A. F. T. Mak and K. D. Yao, Polymer Degrad. Stability, 75, 45, 2002. https://doi.org/10.1016/S0141-3910(01)00203-8
28. X. Y. Yuan, A. F. T. Mak and K. D. Yao, J. Appl. Polymer Scie., 85, 936, 2002. https://doi.org/10.1002/app.10490
29. C. F. Zhang, B. K. Zhu, G. L. Ji and Y. Y. Xu, J Appl Polymer Scie, 103, 1632, 2007. h https://doi.org/10.1002/app.24620
30. M. Zhang, S. L. Chen, S. W. Seto, Y. W. Kwan and S. W. Chan, Pharmaceutical Biology, 47, 366, 2009. https://doi.org/10.1080/13880200902753064
31. J. Zhao, X. Y. Yuan, Y. L. Cui, Q. B. Ge and K. D. Yao, J.Appl.Polymer Scie., 91, 1676, 2004. https://doi.org/10.1002/app.13323
32. G. Zhou, S. Liu, Y. Ma, W. Xu, W. Meng, X. Lin, W. Wang, S. Wang and J. Zhang, Int J Nanomedicine, 12, 7588, 2017.
33. H. G. Zhu, J. Ji and J. C. Shen, Macromol Rapid Communication,.23, 819, 2002. https://doi.org/10.1002/1521-3927(20021001)23:14<819::AID-MARC819>3.0.CO;2-9
.